187 related articles for article (PubMed ID: 35436629)
1. CircRNA608-microRNA222-PINK1 axis regulates the mitophagy of hepatic stellate cells in NASH related fibrosis.
Xu ZX; Li JZ; Li Q; Xu MY; Li HY
Biochem Biophys Res Commun; 2022 Jun; 610():35-42. PubMed ID: 35436629
[TBL] [Abstract][Full Text] [Related]
2. Lipotoxic hepatocyte derived LIMA1 enriched small extracellular vesicles promote hepatic stellate cells activation via inhibiting mitophagy.
Li S; Yang F; Cheng F; Zhu L; Yan Y
Cell Mol Biol Lett; 2024 May; 29(1):82. PubMed ID: 38822260
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-derived exosomal miR-27a activateshepatic stellate cells through the inhibitionof PINK1-mediated mitophagy in MAFLD.
Luo X; Xu ZX; Wu JC; Luo SZ; Xu MY
Mol Ther Nucleic Acids; 2021 Dec; 26():1241-1254. PubMed ID: 34853724
[TBL] [Abstract][Full Text] [Related]
4. The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis.
Liu B; Tian Y; He J; Gu Q; Jin B; Shen H; Li W; Shi L; Yu H; Shan G; Cai X
J Transl Med; 2022 Sep; 20(1):393. PubMed ID: 36058953
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
6. Thymosin-β4 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835/miR-155/FoxO3 Signaling Pathway.
Zhu L; Ren T; Zhu Z; Cheng M; Mou Q; Mu M; Liu Y; Yao Y; Cheng Y; Zhang B; Cheng Z
Cell Physiol Biochem; 2018; 51(3):1389-1398. PubMed ID: 30481761
[TBL] [Abstract][Full Text] [Related]
7. SLC7A11-ROS/αKG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression.
Lv T; Fan X; He C; Zhu S; Xiong X; Yan W; Liu M; Xu H; Shi R; He Q
Redox Biol; 2024 Jun; 72():103159. PubMed ID: 38642501
[TBL] [Abstract][Full Text] [Related]
8. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
10. PM
Wang ZJ; Yu H; Hao JJ; Peng Y; Yin TT; Qiu YN
Exp Cell Res; 2021 Oct; 407(2):112828. PubMed ID: 34508745
[TBL] [Abstract][Full Text] [Related]
11. Diethyldithiocarbamate inhibits the activation of hepatic stellate cells via PPARα/FABP1 in mice with non-alcoholic steatohepatitis.
Sun X; Yu Q; Kang B; Zhao X; Li H; Liu H; Liu L; Wang P; Cong M; Liu T
Biochem Biophys Res Commun; 2023 Jan; 641():192-199. PubMed ID: 36535078
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Mediated RNA Therapy Attenuates Nonalcoholic Steatohepatitis and Related Fibrosis by Targeting Activated Hepatic Stellate Cells.
Zhang C; Teng Y; Li F; Ho W; Bai X; Xu X; Zhang XQ
ACS Nano; 2023 Aug; 17(15):14852-14870. PubMed ID: 37490628
[TBL] [Abstract][Full Text] [Related]
13. MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy.
Dou SD; Zhang JN; Xie XL; Liu T; Hu JL; Jiang XY; Wang MM; Jiang HD
Open Med (Wars); 2021; 16(1):1718-1727. PubMed ID: 34825063
[TBL] [Abstract][Full Text] [Related]
14. Preliminary screening and functional analysis of circular RNAs associated with hepatic stellate cell activation.
Zhou Y; Lv X; Qu H; Zhao K; Fu L; Zhu L; Ye G; Guo J
Gene; 2018 Nov; 677():317-323. PubMed ID: 30118889
[TBL] [Abstract][Full Text] [Related]
15. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance.
Meroni M; Longo M; Erconi V; Valenti L; Gatti S; Fracanzani AL; Dongiovanni P
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31671785
[TBL] [Abstract][Full Text] [Related]
16. Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy.
Jin X; Gao J; Zheng R; Yu M; Ren Y; Yan T; Huang Y; Li Y
Cell Death Dis; 2020 Feb; 11(2):123. PubMed ID: 32054840
[TBL] [Abstract][Full Text] [Related]
17. Aflatoxin B
Yang L; Gao YL; Jiang S; Qian B; Che L; Wu JS; Du ZB; Wang MZ; Yang Y; Lin YC; Liu G; Lin ZN
Ecotoxicol Environ Saf; 2024 Jun; 277():116363. PubMed ID: 38663190
[TBL] [Abstract][Full Text] [Related]
18. Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease.
Luo X; Luo SZ; Xu ZX; Zhou C; Li ZH; Zhou XY; Xu MY
World J Gastroenterol; 2021 Apr; 27(14):1419-1434. PubMed ID: 33911465
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice.
Chung KJ; Legaki AI; Papadopoulos G; Gercken B; Gebler J; Schwabe RF; Chavakis T; Chatzigeorgiou A
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902241
[TBL] [Abstract][Full Text] [Related]
20. MiR-552-3p Regulates Multiple Fibrotic and Inflammatory genes Concurrently in Hepatic Stellate Cells Improving NASH-associated Phenotypes.
Ma N; Hou A; Pan X; Sun F; Xu X; Yu C; Lai R; Huang R; Gong L; Xie Q; Chen J; Ren J
Int J Biol Sci; 2023; 19(11):3456-3471. PubMed ID: 37496991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
